WO2008067551A3 - Genetic analysis systems and methods - Google Patents

Genetic analysis systems and methods Download PDF

Info

Publication number
WO2008067551A3
WO2008067551A3 PCT/US2007/086138 US2007086138W WO2008067551A3 WO 2008067551 A3 WO2008067551 A3 WO 2008067551A3 US 2007086138 W US2007086138 W US 2007086138W WO 2008067551 A3 WO2008067551 A3 WO 2008067551A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
genetic analysis
analysis systems
disease
individual
Prior art date
Application number
PCT/US2007/086138
Other languages
French (fr)
Other versions
WO2008067551A2 (en
Inventor
Dietrich A Stephan
Melissa Floren Filippone
Jennifer Wessel
Michele Cargill
Eran Halperin
Original Assignee
Navigenics Inc
Dietrich A Stephan
Melissa Floren Filippone
Jennifer Wessel
Michele Cargill
Eran Halperin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/781,679 external-priority patent/US20080131887A1/en
Application filed by Navigenics Inc, Dietrich A Stephan, Melissa Floren Filippone, Jennifer Wessel, Michele Cargill, Eran Halperin filed Critical Navigenics Inc
Priority to JP2009539519A priority Critical patent/JP2010522537A/en
Priority to CA002671267A priority patent/CA2671267A1/en
Priority to US12/516,915 priority patent/US9092391B2/en
Priority to CN2007800500195A priority patent/CN101617227B/en
Priority to KR1020097013756A priority patent/KR20090105921A/en
Priority to AU2007325021A priority patent/AU2007325021B2/en
Priority to EP07854875A priority patent/EP2102651A4/en
Publication of WO2008067551A2 publication Critical patent/WO2008067551A2/en
Publication of WO2008067551A3 publication Critical patent/WO2008067551A3/en
Priority to HK10106416.1A priority patent/HK1139737A1/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

The present invention provides methods of determining a Genetic Composite Index score by assessing the association between an individual's genotype and at least one disease or condition. The assessment comprises comparing an individual's genomic profile with a database of medically relevant genetic variations that have been established to associate with at least one disease or condition.
PCT/US2007/086138 2006-11-30 2007-11-30 Genetic analysis systems and methods WO2008067551A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2009539519A JP2010522537A (en) 2006-11-30 2007-11-30 Genetic analysis systems and methods
CA002671267A CA2671267A1 (en) 2006-11-30 2007-11-30 Genetic analysis systems and methods
US12/516,915 US9092391B2 (en) 2006-11-30 2007-11-30 Genetic analysis systems and methods
CN2007800500195A CN101617227B (en) 2006-11-30 2007-11-30 Genetic analysis systems and methods
KR1020097013756A KR20090105921A (en) 2006-11-30 2007-11-30 Genetic analysis systems and methods
AU2007325021A AU2007325021B2 (en) 2006-11-30 2007-11-30 Genetic analysis systems and methods
EP07854875A EP2102651A4 (en) 2006-11-30 2007-11-30 Genetic analysis systems and methods
HK10106416.1A HK1139737A1 (en) 2006-11-30 2010-06-30 Genetic analysis systems and methods

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US86806606P 2006-11-30 2006-11-30
US60/868,066 2006-11-30
US95112307P 2007-07-20 2007-07-20
US60/951,123 2007-07-20
US11/781,679 US20080131887A1 (en) 2006-11-30 2007-07-23 Genetic Analysis Systems and Methods
US11/781,679 2007-07-23
US97219807P 2007-09-13 2007-09-13
US60/972,198 2007-09-13
US98562207P 2007-11-05 2007-11-05
US60/985,622 2007-11-05
US98968507P 2007-11-21 2007-11-21
US60/989,685 2007-11-21

Publications (2)

Publication Number Publication Date
WO2008067551A2 WO2008067551A2 (en) 2008-06-05
WO2008067551A3 true WO2008067551A3 (en) 2008-12-11

Family

ID=38962435

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/086138 WO2008067551A2 (en) 2006-11-30 2007-11-30 Genetic analysis systems and methods

Country Status (10)

Country Link
EP (1) EP2102651A4 (en)
JP (2) JP2010522537A (en)
KR (1) KR20090105921A (en)
CN (1) CN103642902B (en)
AU (1) AU2007325021B2 (en)
CA (1) CA2671267A1 (en)
GB (1) GB2444410B (en)
HK (1) HK1139737A1 (en)
TW (1) TWI363309B (en)
WO (1) WO2008067551A2 (en)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8340950B2 (en) 2006-02-10 2012-12-25 Affymetrix, Inc. Direct to consumer genotype-based products and services
US20080131887A1 (en) 2006-11-30 2008-06-05 Stephan Dietrich A Genetic Analysis Systems and Methods
US7972787B2 (en) 2007-02-16 2011-07-05 Massachusetts Eye And Ear Infirmary Methods for detecting age-related macular degeneration
US7844609B2 (en) 2007-03-16 2010-11-30 Expanse Networks, Inc. Attribute combination discovery
FR2934698B1 (en) * 2008-08-01 2011-11-18 Commissariat Energie Atomique PREDICTION METHOD FOR THE PROGNOSIS OR DIAGNOSIS OR THERAPEUTIC RESPONSE OF A DISEASE AND IN PARTICULAR PROSTATE CANCER AND DEVICE FOR PERFORMING THE METHOD.
EP2321753A1 (en) * 2008-08-08 2011-05-18 Navigenics INC. Methods and systems for personalized action plans
WO2010030929A1 (en) * 2008-09-12 2010-03-18 Navigenics, Inc. Methods and systems for incorporating multiple environmental and genetic risk factors
NZ572036A (en) * 2008-10-15 2010-03-26 Nikola Kirilov Kasabov Data analysis and predictive systems and related methodologies
WO2010067381A1 (en) * 2008-12-12 2010-06-17 Decode Genetics Ehf Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction
US8108406B2 (en) 2008-12-30 2012-01-31 Expanse Networks, Inc. Pangenetic web user behavior prediction system
EP3276526A1 (en) 2008-12-31 2018-01-31 23Andme, Inc. Finding relatives in a database
CA2760439A1 (en) 2009-04-30 2010-11-04 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
WO2010139006A1 (en) * 2009-06-01 2010-12-09 Genetic Technologies Limited Methods for breast cancer risk assessment
DE102010013114B4 (en) * 2010-03-26 2012-02-16 Rüdiger Lawaczeck Prediagnostic safety system
KR20110136638A (en) * 2010-06-15 2011-12-21 재단법인 게놈연구재단 Online social network construction method and system with personal genome data
WO2012006669A1 (en) * 2010-07-13 2012-01-19 Fitgenes Pty Ltd System and method for determining personal health intervention
US20120078901A1 (en) * 2010-08-31 2012-03-29 Jorge Conde Personal Genome Indexer
WO2012054653A2 (en) 2010-10-19 2012-04-26 Medtronic, Inc. Diagnostic kits, genetic markers, and methods for scd or sca therapy selection
CN110838348A (en) * 2010-11-01 2020-02-25 皇家飞利浦电子股份有限公司 In vitro diagnostic test including automated brokering of royalties for proprietary tests
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
US8718950B2 (en) 2011-07-08 2014-05-06 The Medical College Of Wisconsin, Inc. Methods and apparatus for identification of disease associated mutations
EP2761520B1 (en) * 2011-09-26 2020-05-13 Trakadis, John Diagnostic method and system for genetic disease search based on the phenotype and the genome of a human subject
WO2013055911A1 (en) 2011-10-14 2013-04-18 Dana-Farber Cancer Institute, Inc. Znf365/zfp365 biomarker predictive of anti-cancer response
KR101295785B1 (en) * 2011-10-31 2013-08-12 삼성에스디에스 주식회사 Apparatus and Method for Constructing Gene-Disease Relation Database
US10437858B2 (en) 2011-11-23 2019-10-08 23Andme, Inc. Database and data processing system for use with a network-based personal genetics services platform
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
KR20140009854A (en) * 2012-07-13 2014-01-23 삼성전자주식회사 Method and apparatus for analyzing gene information for treatment decision
KR101967248B1 (en) * 2012-08-16 2019-04-10 삼성전자주식회사 Method and apparatus for analyzing personalized multi-omics data
JP5844715B2 (en) 2012-11-07 2016-01-20 学校法人沖縄科学技術大学院大学学園 Data communication system, data analysis apparatus, data communication method, and program
KR101533395B1 (en) * 2013-01-21 2015-07-08 이상열 Method and system estimating resemblance between subject using single nucleotide polymorphism
WO2014119914A1 (en) * 2013-02-01 2014-08-07 에스케이텔레콤 주식회사 Method for providing information about gene sequence-based personal marker and apparatus using same
US8778609B1 (en) 2013-03-14 2014-07-15 Good Start Genetics, Inc. Methods for analyzing nucleic acids
US20140274763A1 (en) * 2013-03-15 2014-09-18 Pathway Genomics Corporation Method and system to predict response to pain treatments
US9192647B2 (en) 2013-10-04 2015-11-24 Hans-Michael Dosch Method for reversing recent-onset type 1 diabetes (T1D) by administering substance P (sP)
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
TW201516725A (en) * 2013-10-18 2015-05-01 Tci Gene Inc Single nucleotide polymorphism disease incidence prediction system
FI20136079A (en) * 2013-11-04 2015-05-05 Medisapiens Oy Genetic health assessment procedure and system
DE202014010499U1 (en) 2013-12-17 2015-10-20 Kymab Limited Targeting of human PCSK9 for cholesterol treatment
KR101400946B1 (en) 2013-12-27 2014-05-29 한국과학기술정보연구원 Biological network analyzing device and method thereof
KR102131973B1 (en) * 2013-12-30 2020-07-08 주식회사 케이티 Method and System for personalized healthcare
WO2015171370A1 (en) 2014-05-05 2015-11-12 Medtronic, Inc. Methods and compositions for scd, crt, crt-d, or sca therapy identification and/or selection
US11053548B2 (en) 2014-05-12 2021-07-06 Good Start Genetics, Inc. Methods for detecting aneuploidy
DE202015009006U1 (en) 2014-07-15 2016-08-19 Kymab Limited Targeting of human PCSK9 for cholesterol treatment
DE202015008974U1 (en) 2014-07-15 2016-06-30 Kymab Limited Targeting of human PCSK9 for cholesterol treatment
EP2975059A1 (en) 2014-07-15 2016-01-20 Kymab Limited Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
WO2016023916A1 (en) 2014-08-12 2016-02-18 Kymab Limited Treatment of disease using ligand binding to targets of interest
JP6682439B2 (en) * 2014-09-03 2020-04-15 大塚製薬株式会社 Pathological condition determination support device, method, program and recording medium
WO2016040446A1 (en) 2014-09-10 2016-03-17 Good Start Genetics, Inc. Methods for selectively suppressing non-target sequences
EP3224595A4 (en) 2014-09-24 2018-06-13 Good Start Genetics, Inc. Process control for increased robustness of genetic assays
WO2016071701A1 (en) 2014-11-07 2016-05-12 Kymab Limited Treatment of disease using ligand binding to targets of interest
EP3271480B8 (en) 2015-01-06 2022-09-28 Molecular Loop Biosciences, Inc. Screening for structural variants
JP2018507470A (en) 2015-01-20 2018-03-15 ナントミクス，エルエルシー System and method for predicting response to chemotherapy for high-grade bladder cancer
WO2016130578A1 (en) * 2015-02-09 2016-08-18 10X Genomics, Inc. Systems and methods for determining structural variation and phasing using variant call data
CA2978708A1 (en) * 2015-03-03 2016-09-09 Nantomics, Llc Ensemble-based research recommendation systems and methods
KR102508971B1 (en) * 2015-07-22 2023-03-09 주식회사 케이티 Method and apparatus for predicting the disease risk
US20170076047A1 (en) * 2015-09-16 2017-03-16 Good Start Genetics, Inc. Systems and methods for genetic testing
EP3350721A4 (en) * 2015-09-18 2019-06-12 Fabric Genomics, Inc. Predicting disease burden from genome variants
KR101795662B1 (en) * 2015-11-19 2017-11-13 연세대학교 산학협력단 Apparatus and Method for Diagnosis of metabolic disease
FR3045874B1 (en) * 2015-12-18 2019-06-14 Axlr, Satt Du Languedoc Roussillon ARCHITECTURE FOR GENOMIC DATA ANALYSIS
JP6776576B2 (en) * 2016-03-28 2020-10-28 富士通株式会社 Database processing program, database processing device and database processing method
KR101991007B1 (en) * 2016-05-27 2019-06-20 (주)메디젠휴먼케어 A system and apparatus for disease-related genomic analysis using SNP
WO2018001761A1 (en) * 2016-06-29 2018-01-04 Koninklijke Philips N.V. Disease-oriented genomic anonymization
KR101815529B1 (en) 2016-07-29 2018-01-30 (주)신테카바이오 Human Haplotyping System And Method
WO2018042185A1 (en) * 2016-09-02 2018-03-08 Imperial Innovations Ltd Methods, systems and apparatus for identifying pathogenic gene variants
CN106778083A (en) * 2016-11-28 2017-05-31 墨宝股份有限公司 A kind of method and device for automatically generating genetic test report
EP3553737A4 (en) * 2016-12-12 2019-11-06 Nec Corporation Information processing device, genetic information creation method, and program
JP7264046B2 (en) * 2017-03-15 2023-04-25 東洋紡株式会社 Genetic test method and genetic test kit
CN108629153A (en) * 2017-03-23 2018-10-09 广州康昕瑞基因健康科技有限公司 Cma gene analysis method and system
WO2019028507A1 (en) * 2017-08-08 2019-02-14 Queensland University Of Technology Methods for diagnosis of early stage heart failure
KR102073590B1 (en) * 2017-08-17 2020-02-06 (주)에이엔티홀딩스 Method, system and non-transitory computer-readable recording medium for providing a service based on genetic information
KR102097540B1 (en) * 2017-12-26 2020-04-07 주식회사 클리노믹스 Method for disease and phenotype risk score calculation
CN108549795A (en) * 2018-03-13 2018-09-18 刘吟 Genetic counselling information system based on pedigree chart frame
GB201810897D0 (en) * 2018-07-03 2018-08-15 Chronomics Ltd Phenotype prediction
CN109355368A (en) * 2018-10-22 2019-02-19 江苏美因康生物科技有限公司 A kind of kit and method of quick detection hypertension individuation medication gene pleiomorphism
US10896742B2 (en) 2018-10-31 2021-01-19 Ancestry.Com Dna, Llc Estimation of phenotypes using DNA, pedigree, and historical data
GB2578727A (en) * 2018-11-05 2020-05-27 Earlham Inst Genomic analysis
EP3899039A4 (en) * 2018-12-20 2022-09-14 The Johns Hopkins University Treating type 1 diabetes, other autoimmune diseases
JP7137520B2 (en) * 2019-04-23 2022-09-14 ジェネシスヘルスケア株式会社 How to determine the risk of pancreatitis
JP7137522B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 How to determine your scoliosis risk
JP7137524B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 Methods for determining risk of knee osteoarthritis
JP7137523B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 How to determine your risk of hives
JP7137526B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 Methods for determining the risk of atopic dermatitis
JP7137521B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 How to determine your risk of psoriasis
JP7137525B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 How to determine the risk of contact dermatitis
KR102357453B1 (en) * 2019-06-24 2022-02-04 (주) 아이크로진 Service method and platform for visualizing using a gene information
KR102091790B1 (en) * 2019-09-02 2020-03-20 주식회사 클리노믹스 System for providng genetic zodiac sign using genetic information between examinees and organisms
KR102151716B1 (en) * 2019-12-06 2020-09-04 주식회사 클리노믹스 System for providing gemetic surmane information using genomic information
KR102179850B1 (en) * 2019-12-06 2020-11-17 주식회사 클리노믹스 System and method for predicting health using analysis device for intraoral microbes (bacteria, virus, viroid, and/or fungi)
KR102136207B1 (en) * 2019-12-31 2020-07-21 주식회사 클리노믹스 Sytem for providing personalized social contents imformation based on genetic information and method thereof
KR102138165B1 (en) * 2020-01-02 2020-07-27 주식회사 클리노믹스 Method for providing identity analyzing service using standard genome map database by nationality, ethnicity, and race
KR102223362B1 (en) * 2020-08-10 2021-03-05 주식회사 쓰리빌리언 System and method to identify disease associated genetic variants by using symptom associated genetic variants relationship
KR102223361B1 (en) * 2020-09-23 2021-03-05 주식회사 쓰리빌리언 System for diagnosing genetic disease using gene network
CN113921143B (en) * 2021-10-08 2024-04-16 天津金域医学检验实验室有限公司 Personalized estimation method and system for Bayes factors in coseparation analysis
CN114360732B (en) * 2022-01-12 2024-04-09 平安科技（深圳）有限公司 Medical data analysis method, device, electronic equipment and storage medium

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128860A1 (en) * 2001-01-04 2002-09-12 Leveque Joseph A. Collecting and managing clinical information
US20030046110A1 (en) * 2001-08-29 2003-03-06 Victor Gogolak Method and system for creating, storing and using patient-specific and population-based genomic drug safety data
US20030104453A1 (en) * 2001-11-06 2003-06-05 David Pickar System for pharmacogenetics of adverse drug events
US20030208454A1 (en) * 2000-03-16 2003-11-06 Rienhoff Hugh Y. Method and system for populating a database for further medical characterization

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000067139A (en) * 1998-08-25 2000-03-03 Hitachi Ltd Electronic medical sheet system
EP2899660A1 (en) * 1999-08-27 2015-07-29 Iris Biotechnologies Inc. Artificial intelligence system for genetic analysis
AU1367201A (en) * 1999-10-01 2001-05-10 Orchid Biosciences, Inc. Method and system for providing genotype clinical information over a computer network
JP2002107366A (en) * 2000-10-02 2002-04-10 Hitachi Ltd Diagnosis-assisting system
WO2002063415A2 (en) * 2000-12-04 2002-08-15 Genaissance Pharmaceuticals, Inc. System and method for the management of genomic data
US20020187483A1 (en) * 2001-04-20 2002-12-12 Cerner Corporation Computer system for providing information about the risk of an atypical clinical event based upon genetic information
US20040053263A1 (en) * 2002-08-30 2004-03-18 Abreu Maria T. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
WO2004109551A1 (en) * 2003-06-05 2004-12-16 Hitachi High-Technologies Corporation Information providing system and program using base sequence related information
GB0313964D0 (en) * 2003-06-16 2003-07-23 Mars Inc Genotype test
US7084264B2 (en) * 2003-07-16 2006-08-01 Chau-Ting Yeh Viral sequences
US8222005B2 (en) * 2003-09-17 2012-07-17 Agency For Science, Technology And Research Method for gene identification signature (GIS) analysis
EP1684202A4 (en) * 2003-10-15 2007-10-03 Signpost Corp Method of determining genetic polymorphism for judgment of degree of disease risk, method of judging degree of disease risk, and judgment array
US20050209787A1 (en) * 2003-12-12 2005-09-22 Waggener Thomas B Sequencing data analysis
US7127355B2 (en) * 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis
US20070265217A1 (en) * 2004-07-16 2007-11-15 Bayer Healthcare Ag Single Nucleotide Polymorphisms as Prognostic Tool to Diagnose Adverse Drug Reactions (Adr) and Drug Efficacy
AU2005305765A1 (en) * 2004-11-19 2006-05-26 Oy Jurilab Ltd Method and kit for detecting a risk of essential arterial hypertension

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030208454A1 (en) * 2000-03-16 2003-11-06 Rienhoff Hugh Y. Method and system for populating a database for further medical characterization
US20020128860A1 (en) * 2001-01-04 2002-09-12 Leveque Joseph A. Collecting and managing clinical information
US20030046110A1 (en) * 2001-08-29 2003-03-06 Victor Gogolak Method and system for creating, storing and using patient-specific and population-based genomic drug safety data
US20030104453A1 (en) * 2001-11-06 2003-06-05 David Pickar System for pharmacogenetics of adverse drug events

Also Published As

Publication number Publication date
TWI363309B (en) 2012-05-01
AU2007325021B2 (en) 2013-05-09
GB0723512D0 (en) 2008-01-09
CN103642902A (en) 2014-03-19
AU2007325021A1 (en) 2008-06-05
TW200847056A (en) 2008-12-01
CA2671267A1 (en) 2008-06-05
JP2010522537A (en) 2010-07-08
GB2444410B (en) 2011-08-24
WO2008067551A2 (en) 2008-06-05
JP2014140387A (en) 2014-08-07
HK1139737A1 (en) 2010-09-24
KR20090105921A (en) 2009-10-07
CN103642902B (en) 2016-01-20
EP2102651A4 (en) 2010-11-17
GB2444410A (en) 2008-06-04
EP2102651A2 (en) 2009-09-23

Similar Documents

Publication Publication Date Title
WO2008067551A3 (en) Genetic analysis systems and methods
GB2477868A (en) Methods and systems for incorporating multiple environmental and genetic risk factors
WO2009117122A8 (en) Genetic analysis
WO2007130831A3 (en) Methods and apparatus for identifying disease status using biomarkers
WO2005086770A3 (en) Methods for genetic analysis
WO2006047787A3 (en) Method for monitoring disease progression or recurrence
WO2006084195A3 (en) Personal assessment including familial risk analysis for personalized disease prevention plan
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
WO2005111999A3 (en) System and method for analyzing and improving a discourse engaged in by a number of interacting agents
AU2008304205A8 (en) Methods and systems for genomic analysis using ancestral data
WO2008017002A3 (en) Polymorphisms in genes affecting cns disorders and uses thereof
WO2007115095A3 (en) Systems and methods for using molecular networks in genetic linkage analysis of complex traits
WO2008068780A3 (en) Genetic markers for risk management of cardiac arrhythmia
WO2007038670A3 (en) Methods and compositions for screening and treatment of disorders of blood glucose regulation
WO2007120480A3 (en) Systems and methods for predicting effectiveness in the treatment of psychiatric disorders, including depression
WO2009085689A3 (en) Methods of improving genetic profiles of dairy animals and products
WO2008136988A3 (en) Polymorphisms in genes affecting cyp2c9-related disorders and uses thereof
WO2007134235A3 (en) Hla alleles associated with adverse drug reactions and methods for detecting such
NZ591236A (en) Methods for determining a breeding value based on a plurality of genetic markers
WO2009041501A1 (en) Factor involved in latent infection with herpesvirus, and use thereof
WO2008033427A3 (en) Compositions and methods for detection of lysosomal storage disease
WO2010103292A3 (en) A genotyping tool for improving the prognostic and clinical management of ms patients
WO2009062166A3 (en) Dna microarray based identification and mapping of balanced translocation breakpoints
WO2005072151A3 (en) Apoe genetic markers associated with age of onset of alzheimer's disease
WO2006026074A3 (en) Atherosclerotic phenotype determinative genes and methods for using the same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780050019.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07854875

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2009539519

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2671267

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007325021

Country of ref document: AU

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2007325021

Country of ref document: AU

Date of ref document: 20071130

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2007854875

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020097013756

Country of ref document: KR

Ref document number: 2007854875

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12516915

Country of ref document: US